申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US04935418A1
公开(公告)日:1990-06-19
The invention relates to 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines of the formula ##STR1## wherein Y is the same or different and is hydrogen and lower alkoxy; X is hydrogen, halogen, lower alkyl, lower alkoxy, CF.sub.3, NO.sub.2, CN and NH.sub.2 ; R is hydrogen, lower alkyl, cycloalkyllower alkyl, ##STR2## Ar lower alkyl of the formula ##STR3## where Z is hydrogen, lower alkyl, lower alkoxy, halogen CF.sub.3, NO.sub.2 and NH.sub.2 ; Aryloxy lower alkyl of the formula ##STR4## where Z is as previously defined; and an alkylene amine of the formula ##STR5## where R.sub.1 and R.sub.2 are the same or different and are hydrogen and lower alkyl, n is an integer of 1 or 2; and the pharmaceutically acceptable acid addition salts thereof.
本发明涉及式子##STR1##中的1-芳氧基-2,3,4,5-四氢-3-苯并哌啶;其中Y相同或不同,是氢和低级烷氧基;X是氢、卤素、低级烷基、低级烷氧基、CF.sub.3、NO.sub.2、CN和NH.sub.2;R是氢、低级烷基、环烷基低级烷基、##STR2## Ar低级烷基的式子##STR3##其中Z是氢、低级烷基、低级烷氧基、卤素CF.sub.3、NO.sub.2和NH.sub.2;芳氧基低级烷基的式子##STR4##其中Z如前所述;以及式子##STR5##中的烷基胺,其中R.sub.1和R.sub.2相同或不同,是氢和低级烷基,n是1或2的整数;以及其药学上可接受的酸盐。